NCT00368602

Beta Blocker for Chronic Wound Healing

Beta Adrenergic Receptor Modulation of Burn Wound Healing

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: University of California, Davis · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of treatment of chronic cutaneous ulcers and burn wounds with topical beta adrenergic antagonists (Timoptic®).

Detailed description

The purpose of this study is to learn more about how to heal venous leg ulcers faster and to test the safety of a drug and see what effects it has on a venous leg ulcer. You will: * be interviewed and examined * have a physical exam * have blood and urine tested * have photographs taken of the wound * apply medication to the leg ulcer as directed

Conditions

• Ulcer
• Burns

Interventions

Type	Name	Description
DRUG	Timoptic	Timoptic to be applied to the target wound daily for up to 12 weeks.
OTHER	Placebo	Saline solution with no active ingredients to be applied to the target wound daily for up to 12 weeks.

Timeline

• Start date: 2005-06-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2006-08-25
• Last updated: 2015-04-07

Locations

1 site across 1 country: United States